title: [Antiviral therapy in a patient with chronic hepatitis C, metabolic syndrome and interferon-induced depression].
abstract: A case of metabolic syndrome is reported in which its elimination before the onset of antiviral treatment of chronic hepatitis A and drug therapy of subsequent depression promoted successful outcome with a stable virological response. Modern approaches are discussed to enhancing efficiency of antiviral therapy by active correction of factors responsible for poor results of the treatment and its undesirable consequences.
authors.forename: Zh Zh
authors.initials: ZhZh
authors.lastname: Baĭzhanova
authors.forename: T M
authors.initials: TM
authors.lastname: Ignatova
authors.forename: M A
authors.initials: MA
authors.lastname: Kinkul'kina
mesh_terms: D000328:Adult; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003863:Depression / Q000139:chemically induced* / Q000150:complications / Q000188:drug therapy; D004359:Drug Therapy, Combination; D005081:Exercise Therapy / Q000379:methods*; D005260:Female; D005500:Follow-Up Studies; D019698:Hepatitis C, Chronic / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D024821:Metabolic Syndrome / Q000150:complications* / Q000628:therapy; D011092:Polyethylene Glycols / Q000009:adverse effects* / Q000627:therapeutic use; D011994:Recombinant Proteins; D013841:Thiazepines / Q000627:therapeutic use
chemical_list: D000929:Antidepressive Agents, Tricyclic; D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D013841:Thiazepines; C050504:tianeptine; D011092:Polyethylene Glycols; C417083:peginterferon alfa-2b